Cytotoxicity and Surface Area Analysis of Silver Nanoparticles Encapsulated in Liposomes, PVP, and BSA: Effects on Caco-2 and U251 Cells
Authors:
- Muhammad Zia Ul HaqMHMuhammad Zia Ul Haq
- Furong TianFurong Tian
Open Access
- 1 December 2025
- journal article
- Published by Tsinghua University Press in Nano Biomedicine and Engineering
- Vol. 17 (4) , 505-516
Abstract
Particle size and shape of cells are essential determining the outcome of drug delivery of nano carrier for medical applications. In this study, different size silver nanoparticles were controllably synthesized to treat two shapes of cells. Silver nanoparticles (AgNPs) were synthesized via chemical reduction using NaBH4 and modified with polyvinylpyrrolidone (PVP) and bovine serum albumin (BSA) or encapsulated in liposomes to enhance cellular uptake. Different nanoparticle sizes were obtained as follows: uncapped AgNPs (30 nm), PVP–AgNPs (34.7 nm), BSA–AgNPs (113.9–145.2 nm), and liposome-encapsulated AgNPs (70.9–142.0 nm). Liposomes with a 5:3 molar ratio of dipalmitoylphosphatidylcholine (DPPC) -to-cholesterol formed stable vesicles, each encapsulating up to 66 AgNPs at a concentration of 2 mmol/L. Cytotoxicity assays revealed that uncapped 2 mM AgNPs exhibited strong toxicity toward both Caco-2 and U251 cells (IC50: 13.52 µmol/L at 24 h). Liposomal AgNPs displayed concentration-dependent effects, with 1 mM AgNPs–liposomes exhibiting the highest toxicity toward Caco-2 cells (IC50: 0.5 µmol/L at 24 h), but significantly lower toxicity toward U251 cells (IC50: 134.3 µmol/L at 24 h). The formulation exhibiting the highest toxicity at 48 h was 2 mmol/L AgNPs–liposomes against Caco-2 cells (IC50: 4.6 µmol/L). In contrast, BSA and PVP coatings significantly reduced toxicity, with IC50 of 2.2 µmol/L for 50 mmol/L BSA–AgNPs and 14.9 µmol/L for 50 mmol/L PVP–AgNPs in Caco-2 cells. Liposome-encapsulated AgNPs showed enhanced toxicity against square-shaped Caco-2 cells compared to fibroblast-like U251 cells (p < 0.05), highlighting their potential for targeted cancer therapy. The findings of this study demonstrate that surface modifications and encapsulation strategies critically influence the biological effects of AgNPs in liposomes, providing a promising approach for enhanced anticancer activity.Keywords
This publication has 30 references indexed in Scilit:
- Green synthesis and characterization of AgNPs, liposomal loaded AgNPs and ZnPcS4 photosensitizer for enhanced photodynamic therapy effects in MCF-7 breast cancer cellsPhotodiagnosis and Photodynamic Therapy, 2024
- Insight into the molecular mechanism, cytotoxic, and anticancer activities of phyto‐reduced silver nanoparticles in MCF‐7 breast cancer cell linesMicroscopy Research and Technique, 2024
- Fluorescent quantum dots: An insight on synthesis and potential biological application as drug carrier in cancerBiochemistry and Biophysics Reports, 2021
- Grand challenges in nanomedicineMaterials Science and Engineering: C, 2020
- Synthesis of silver nanoparticles with different shapesArabian Journal of Chemistry, 2019
- Extremely concentrated silver nanoparticles stabilized in aqueous solution by Bovine Serum Albumin (BSA)Nano-Structures & Nano-Objects, 2019
- A systematic review on silver nanoparticles-induced cytotoxicity: Physicochemical properties and perspectivesJournal of Advanced Research, 2018
- Liposomal encapsulation of silver nanoparticles enhances cytotoxicity and causes induction of reactive oxygen species‐independent apoptosisJournal of Applied Toxicology, 2017
- Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter?Toxicology Letters, 2017
- Mechanisms of PVP in the preparation of silver nanoparticlesMaterials Chemistry and Physics, 2005